twelve patients ( 2 with only bone metastases , 3 with only soft tissues metastases and 7 with bone and soft tissues metastases ) were treated with 131-i-mibg ( specific activity : 20 mci/mg ) , 100 to 200 mci every 3-6 months .
C0153690
bone metastases
C0262950
bone